Form D · Other

Prairie Pharms, LLC

Nora Springs, IA · CIK 0001552063

Offering snapshot reported Apr 21, 2016 · SEC filing

Reported sold
Yet to sell
Offering amount: $12M
Investors reported
0
Form D · investor count
Minimum accepted
$60K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 21, 2016InitialYet to sellNo comparison0SEC filing
May 30, 2013Initial$455,000No comparison14SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-261807

Source: Form D, filed Apr 21, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Relher Director
Bill Rohlfsen Executive
William Rohlfsen Director, Executive
Nicholas Rohlfsen Director
Joseph Saluri Director

Issuer details

Industry: Other (See others in industry)

Address:
3261 Cameo Avenue
Nora Springs, IA, 50428